Dong Yang

1.7k total citations · 1 hit paper
53 papers, 1.2k citations indexed

About

Dong Yang is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Dong Yang has authored 53 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 23 papers in Molecular Biology and 13 papers in Immunology. Recurrent topics in Dong Yang's work include CAR-T cell therapy research (15 papers), Immune Cell Function and Interaction (10 papers) and Cancer Genomics and Diagnostics (6 papers). Dong Yang is often cited by papers focused on CAR-T cell therapy research (15 papers), Immune Cell Function and Interaction (10 papers) and Cancer Genomics and Diagnostics (6 papers). Dong Yang collaborates with scholars based in China, United States and Australia. Dong Yang's co-authors include Xudong Zhao, Bin Sun, Funda Meric‐Bernstam, Vivek Subbiah, Alexander Drilon, Vamsidhar Velcheti, Xiuyun Liu, Wenxuan Li, Xiaoyue Cui and Hongjiu Dai and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Dong Yang

50 papers receiving 1.2k citations

Hit Papers

NKG2D-CAR T cells eliminate senescent cells in aged mice ... 2023 2026 2024 2025 2023 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dong Yang China 19 553 503 328 249 217 53 1.2k
Long Yuan China 24 640 1.2× 849 1.7× 378 1.2× 189 0.8× 261 1.2× 56 1.7k
Hudie Wei China 14 550 1.0× 835 1.7× 211 0.6× 142 0.6× 220 1.0× 31 1.5k
Masayuki Nagahashi Japan 14 394 0.7× 503 1.0× 155 0.5× 178 0.7× 287 1.3× 27 1.0k
Ashish Juvekar United States 11 468 0.8× 804 1.6× 184 0.6× 131 0.5× 316 1.5× 22 1.3k
Jingkun Qu China 19 414 0.7× 628 1.2× 315 1.0× 193 0.8× 275 1.3× 51 1.3k
Sven A. Lang Germany 24 449 0.8× 928 1.8× 218 0.7× 174 0.7× 298 1.4× 44 1.5k
Girieca Lorusso Switzerland 19 553 1.0× 603 1.2× 304 0.9× 126 0.5× 271 1.2× 25 1.3k
Zhengtang Chen China 24 813 1.5× 835 1.7× 345 1.1× 196 0.8× 396 1.8× 49 1.6k
Willie Wilson United States 10 657 1.2× 667 1.3× 410 1.3× 226 0.9× 257 1.2× 20 1.4k
Evangelos Koustas Greece 19 702 1.3× 642 1.3× 223 0.7× 197 0.8× 348 1.6× 53 1.4k

Countries citing papers authored by Dong Yang

Since Specialization
Citations

This map shows the geographic impact of Dong Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong Yang more than expected).

Fields of papers citing papers by Dong Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong Yang. The network helps show where Dong Yang may publish in the future.

Co-authorship network of co-authors of Dong Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Dong Yang. A scholar is included among the top collaborators of Dong Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong Yang. Dong Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Ziyun, et al.. (2025). Single-cell multi-omics reveals SLC2A1-driven glycolytic reprogramming of pulmonary endothelial cells in sepsis-associated lung injury. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1872(1). 168050–168050.
2.
Sun, Heng, Xin Jia, Dong Yang, et al.. (2024). FLOWERING LOCUS T genes control floral induction in lotus. Plant Physiology and Biochemistry. 207. 108339–108339. 3 indexed citations
3.
Sun, Heng, Gangqiang Dong, Xin Jia, et al.. (2024). NnSBE1 encodes a starch branching enzyme involved in starch biosynthesis in lotus seeds. International Journal of Biological Macromolecules. 279(Pt 1). 135104–135104. 1 indexed citations
4.
Jia, Xin, Dong Yang, Gangqiang Dong, et al.. (2024). NnSUS1 encodes a sucrose synthase involved in sugar accumulation in lotus seed cotyledons. Plant Physiology and Biochemistry. 210. 108591–108591. 4 indexed citations
5.
Zhang, Hang, Jing Guo, Dong Yang, et al.. (2024). A novel bispecific T-cell engager using the ligand-target csGRP78 against acute myeloid leukemia. Cellular and Molecular Life Sciences. 81(1). 371–371. 3 indexed citations
6.
Yang, Dong, Bin Sun, Shirong Li, et al.. (2023). NKG2D-CAR T cells eliminate senescent cells in aged mice and nonhuman primates. Science Translational Medicine. 15(709). eadd1951–eadd1951. 114 indexed citations breakdown →
7.
Wei, Wenwen, Dong Yang, Bin Sun, et al.. (2023). SECTM1-based CAR T cells enriched with CD7-low/negative subsets exhibit efficacy in CD7-positive malignancies. Blood Advances. 7(13). 2941–2951. 6 indexed citations
8.
Fan, Jiawei, Lanzhen Yan, Bin Sun, et al.. (2023). GAS6-based CAR-T cells exhibit potent antitumor activity against pancreatic cancer. Journal of Hematology & Oncology. 16(1). 77–77. 16 indexed citations
9.
Li, Shirong, Bin Sun, Weiyan Peng, et al.. (2023). The stability of FKBP9 maintained by BiP is crucial for glioma progression. Genes & Diseases. 11(6). 101123–101123.
10.
Wang, Shijie, Wenwen Wei, Bin Sun, et al.. (2023). Chimeric antigen receptor T cells targeting cell surface GRP78 efficiently kill glioblastoma and cancer stem cells. Journal of Translational Medicine. 21(1). 493–493. 20 indexed citations
11.
Hsiehchen, David, Dong Yang, Muhammad Shaalan Beg, et al.. (2022). Genetic features and therapeutic relevance of emergent circulating tumor DNA alterations in refractory non-colorectal gastrointestinal cancers. Nature Communications. 13(1). 7477–7477. 9 indexed citations
12.
He, Shuai, Shirong Li, Jing Guo, et al.. (2022). CD166-specific CAR-T cells potently target colorectal cancer cells. Translational Oncology. 27. 101575–101575. 18 indexed citations
13.
Zhang, Yingyi, Shuangshuang Wu, Rui Zhao, et al.. (2022). Peripheral blood circular RNA hsa_circ_0058493 as a potential novel biomarker for silicosis and idiopathic pulmonary fibrosis. Ecotoxicology and Environmental Safety. 236. 113451–113451. 27 indexed citations
15.
Sun, Bin, Dong Yang, Hongjiu Dai, et al.. (2019). Eradication of Hepatocellular Carcinoma by NKG2D-Based CAR-T Cells. Cancer Immunology Research. 7(11). 1813–1823. 115 indexed citations
16.
Jin, Qiong, Dong Yang, Zhi Dai, et al.. (2018). Antitumor aporphine alkaloids from Thalictrum wangii. Fitoterapia. 128. 204–212. 27 indexed citations
17.
Lakhani, Nehal J., Michael Boyer, Drew Rasco, et al.. (2018). OA12 A Phase I Study of Novel Bcl-2/Bcl-xL Inhibitor APG-1252 in Patients with Advanced SCLC or Other Solid Tumor. Journal of Thoracic Oncology. 13(12). S1048–S1049. 3 indexed citations
18.
Yang, Dong, Bin Sun, Xiaohong Zhang, et al.. (2017). Huwe1 Sustains Normal Ovarian Epithelial Cell Transformation and Tumor Growth through the Histone H1.3- H19 Cascade. Cancer Research. 77(18). 4773–4784. 37 indexed citations
19.
Francis, Ashleigh M., Angela Alexander, Yanna Liu, et al.. (2017). CDK4/6 Inhibitors Sensitize Rb-positive Sarcoma Cells to Wee1 Kinase Inhibition through Reversible Cell-Cycle Arrest. Molecular Cancer Therapeutics. 16(9). 1751–1764. 41 indexed citations
20.
Chen, Xian, Tuyen Bui, Yufeng Jiang, et al.. (2016). Sequential Combination Therapy of CDK Inhibition and Doxorubicin Is Synthetically Lethal in p53-Mutant Triple-Negative Breast Cancer. Molecular Cancer Therapeutics. 15(4). 593–607. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026